Bioscience

Biozona Weekly: Pancreatic cancer drug extends life; Bioscience Roadmap featured on TV, radio; TGen event features scientists, baseball commissioner

January 25, 2013

By Flinn Foundation

ASU President Crow sets lofty goals
1/24/2013 | Arizona Republic | Anne Ryman

Arizona State University President Michael Crow,  in a speech to university supporters titled “2013 and Beyond,” said he wants to increase research funding to $700 million a year from $385 million, graduate 25,000 students a year by 2020, and ramp up the number of online degrees.

Old drug extends life for pancreatic cancer patients

1/23/2013 | NPR | Richard Knox

A large study is providing a rare glimmer of hope for patients with pancreatic cancer, perhaps the deadliest of all malignancies, as a two-drug combination extends life for such patients compared to standard chemotherapy.

Study on cancer has Valley link
1/22/2013 | Arizona Republic | Ken Alltucker

Dr. Daniel Von Hoff, chief scientific officer for Scottsdale Healthcare’s clinical trials and Translational Genomics Research Institute’s physician in chief, was the lead investigator of the study which showed increased survival  by nearly two months for people with late-stage pancreatic cancer.

Arizona’s Bioscience Roadmap after ten years
1/21/2013 | KJZZ (91.5) | Morning Edition

Arizona’s Bioscience Roadmap, which has been in place for a decade, is a strategy for the state to compete for higher-paying science jobs that could also lead to medical advancements. 

Bio-tech in Tucson growing, but has challenges

1/18/2013 | Inside Tucson Business | Patrick McNamara

Mara Aspinall, president of Ventana Medical Systems; Kathleen Perkins, board chair University of Arizona Bio 5; and Dr. Carolyn Compton, CEO and president of the Critical Path Institute (C-Path) spoke recently to a Greater Tucson Leadership class about the strengths and challenges of the local bio-tech sector.

What I learned from Bud Selig and some top scientists in Arizona

1/17/2013 | Phoenix Business Journal | Angela Gonzales

More than 280 scientists and business leaders attended a panel discussion sponsored by TGen featuring top researchers and speaker Allan “Bud” Selig, commissioner of Major League Baseball. 

Technology & Innovation: Arizona’s Bioscience Roadmap
1/16/2013 | KAET-8 | Arizona Horizon

The 10th anniversary of Arizona’s Bioscience Roadmap was celebrated recently. The Roadmap helped lead to the development of the Arizona bioscience sector. Find out more about the Roadmap, its development, and the status of Arizona’s bioscience sector from Marty Shultz, chairman of the Bioscience Roadmap Steering Committee, and Brad Halvorsen of the Flinn Foundation.